Cetera Investment Advisers’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Cetera Investment Advisers’s Portfolio PTX Stock Details PTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-46,750	Closed	-$20K	–	506
2018 Q4	$20K	Hold	46,750	–	–	﹤0.01%	449
2018 Q3	$44K	Hold	46,750	–	–	0.01%	479
2018 Q2	$113K	Hold	46,750	–	–	0.02%	415
2018 Q1	$112K	Hold	46,750	–	–	0.02%	380
2017 Q4	$112K	Hold	46,750	–	–	0.02%	405
2017 Q3	$147K	Hold	46,750	–	–	0.03%	381
2017 Q2	$188K	Buy	+46,750	New	+$204K	0.05%	365

Cetera Investment Advisers's PTX Position: Q1 2019 in Review

Cetera Investment Advisers sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q1 2019, closing a stake of 46,750 shares — an estimated $20K sold.

Cetera Investment Advisers first reported a position in PTX in Q2 2017 and held it in 7 quarters. The position peaked at $188K in Q2 2017. 1 fund tracked by Wall St. Rank holds PTX as of Q1 2019.

Cetera Investment Advisers reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q1 2019 after selling out during the quarter.
Cetera Investment Advisers sold 46,750 Pernix Therapeutics Holdings, Inc. shares in Q1 2019, an estimated $20K.
Cetera Investment Advisers first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2017 and held it in 7 quarters.
Cetera Investment Advisers's Pernix Therapeutics Holdings, Inc. position peaked at $188K in Q2 2017.
1 fund tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q1 2019.

Based on Cetera Investment Advisers's 13F filing for Q1 2019, filed 6 May 2019.